Cargos activos de Stella Sarraf
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Spinogenix, Inc.
 Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA. | Director/Miembro de la Junta | 01/01/2016 | - |
| Director Ejecutivo | 01/01/2016 | - | |
| Fundador | 01/01/2016 | - | |
| Presidente | 01/01/2016 | - | |
Amydis, Inc.
 Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services This technology allows physicians and researchers to explore the eye for a broad spectrum of diseases, which have previously required long-term clinical evaluation and invasive testing for definitive diagnosis. Amydis has a discovery platform and proprietary know-how that positions it as a first mover and leader in developing ocular tracers for human diseases. The American company was founded in 2013 by Stella Sarraf, who has been the CEO since then. | Director/Miembro de la Junta | 01/01/2013 | - |
| Director Ejecutivo | 01/01/2013 | - | |
| Fundador | 01/01/2013 | - |
Historial de carrera de Stella Sarraf
Estadísticas
Internacional
| Estados Unidos | 3 |
Operativa
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectorial
| Health Technology | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Spinogenix, Inc.
Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA. | Health Technology |
Amydis, Inc.
Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services This technology allows physicians and researchers to explore the eye for a broad spectrum of diseases, which have previously required long-term clinical evaluation and invasive testing for definitive diagnosis. Amydis has a discovery platform and proprietary know-how that positions it as a first mover and leader in developing ocular tracers for human diseases. The American company was founded in 2013 by Stella Sarraf, who has been the CEO since then. | Commercial Services |
- Bolsa de valores
- Insiders
- Stella Sarraf
- Experiencia
